New anthracycline metabolites produced by the aklavinone 11-hydroxylase gene in Streptomyces galilaeus ATCC 31133

Journal of Antibiotics

Volumn 49, Issue 4, 1996, Pages 355-360

  Kim, Hang Sub ^b   Hong, Young Soo ^a   Kim, Young Ho ^a   Yoo, Ook Joon ^a   Lee, Jung Joon ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

11 HYDROXYACLACINOMYCIN X; ACLACINOMYCIN; ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC ANTIBIOTIC; UNCLASSIFIED DRUG;

ANTIBIOTIC BIOSYNTHESIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG PURIFICATION; DRUG STRUCTURE; GENETIC TRANSFORMATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MELANOMA CELL; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STREPTOMYCES;

EID: 0029873060     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.49.355     Document Type: Article

References (13)

1. ARCAMONE, F.; G. CASSINELLI, G. FANTINI, A. GREIN, P. OREZZI, C. POLI & C. SPALLA: Adriamycin, 14-hydroxy daunomycin, a new antitumor antibiotic from Streptomyces peucetius var. caesius. Biotechnol. Bioeng. 11: 1101-1110, 1969
2. OKI, T.; I. KITAMURA, Y. MATSUZAWA, N. SHIBARMOTO, T. OGASAWARA, A. YOSHIMOTO, T. INUI, H. NAGANAWA, T. TAKEUCHI & H. UMEZAWA: Antitumor anthracyclinc antibiotics, aclacinomycin A and analogues. II. Structural determination. J. Antibiotics 32: 801-819, 1979
3. MYERS, C. E.; E. G. MIMNAUGH, G. C. YEH & B. K. SINHA: Biochemical mechanisms of tumor cell kill by anthracyclines, In Anthracycline and anthracenedionebased anticancer agents. Ed., J. W. LOWN, pp. 527-569, Elsevier, Amsterdam, 1988
4. JOHDO, O.; Y. WATANABE, T. ISHIKURA, A. YOSHIMOTO, H. NAGANAWA, T. SAWA & T. TAKEUCHI: Anthracycline metabolites from Streptomyces violaceus A262. II. New anthracycline epelmycins produced by a blocked mutant strain SU2-730. J. Antibiotics 44: 1121-1129, 1991
5. YOSHIMOTO, A.; S. FUJII, O. JOHDO, K. KUBO, T. ISHIKURA, H. NAGANAWA, T. SAWA, T. TAKEUCHI & H. UMEZAWA: Intensely potent anthracycline antibiotic oxaunomycin produced by a blocked mutant of the daunorubicin-producing microorganism. J. Antibiotics 39 : 902-909, 1986
6. NAKAGAWA, M.; K. FURIHATA, K. FURIHATA, K. ADACHI, H. SETO & N. OTAKE: The structure of a new anthracycline, cinerubicin X produced by a blocked mutant of Streptomyces violaceochromogenes. J. Antibiotics 39: 1178-1179, 1986
7. HWANG, C. K.; H. S. KIM, Y.-S. HONG, Y. H. KIM, S.-K. HONG, S.-J. KIM & J. J. LEE: Expression of Streptomyces peucetius genes for doxorubicin resistance and aklavinone 11-hydroxylase in Streptomyces galilaeus ATCC 31133 and production of a hybrid aclacinomycin. Antimicrob. Agents Chemother. 39: 1616-1620, 1995
8. NIEMI, J.; K. YLIHONKO, J. HAKALA, R. PARSSINEN, A. KOPIO & P. MANTSALA: Hybrid anthracycline antibiotics : Production of new anthracyclines by cloned genes from Streptomyces purpurascens in Streptomyces galilaeus. Microbiology 140: 1351-1358, 1995
9. HONG, Y.-S.; C. K. HWANG, S.-K. HONG, Y. H. KIM & J. J. LEE: Molecular cloning and characterization of the aklavinone 11-hydroxylase gene of Streptomyces peucetius subsp. caesius ATCC 27952. J. Bacteriol. 176: 7096-7101, 1994
10. HOPWOOD, D. A.; M. J. BIBB, K. F. CHATER, T. KIESER, C. J. BRUTON, H. M. KIESER, D. J. LYDIATE, C. P. SMITH, J. M. WARD & H. SCHREMPF: Genetic manipulations of Streptomyces: A laboratory manual. The John Innes Foundation, Norwich, United Kingdom, 1985
11. DOYLE, T. S.; D. E. NETTLETON, R. E. GRULICH, D. M. BALITZ, D. L. JOHNSON & A. L. VULCANO: Antitumor agents from the bohemic acid complex. 4. Structures of rudolphomycin, mimimycin, collinemycin, and alcindoromycin. J. Am. Chem. Soc. 101: 7041-7049, 1979
12. MATSUZAWA, Y.; A. YOSHIMOTO, T. OKI, H. NAGANAWA, T. TAKEUCHI & H. UMEZAWA: Biosynthesis of anthracycline antibiotics by Streptomyces galilaeus. II. Structure of new anthracycline antibiotics obtained by microbial glycosidation and biological activity. J. Antibiotics 33: 1341-1347, 1980
13. MONKS, A.; D. SCUDIERO, P. SKEHAN, R. SHOEMAKER, K. PAULL, D. VISTICA, C. HOSE, J. LANGLEY, P. CRONISE, A. VAIGRO-WOLFF, M. GRAY-GOODRICH, H. CAMPBELL, J. MAYO & M. BOYD: Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J. Natl. Cancer Inst. 83: 757-766, 1991